Regressive changes in leprosy under promin therapy. 1946

G L FITE, and F GEMAR

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl

Related Publications

G L FITE, and F GEMAR
January 1947, Fontilles,
G L FITE, and F GEMAR
January 1948, International journal of Leprosy,
G L FITE, and F GEMAR
December 1946, International journal of Leprosy,
G L FITE, and F GEMAR
May 1965, Vestnik dermatologii i venerologii,
G L FITE, and F GEMAR
October 1946, Leprosy review,
G L FITE, and F GEMAR
April 1949, The Antiseptic,
G L FITE, and F GEMAR
January 1947, Hawaii medical journal,
G L FITE, and F GEMAR
January 1945, American professional pharmacist,
G L FITE, and F GEMAR
January 1948, International journal of Leprosy,
G L FITE, and F GEMAR
January 1966, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
Copied contents to your clipboard!